{
  "url": "https://openlegislation.uk/medicines-fees-relating-to-medicinal-products-for-animal-use-regulations-1992/schedule-1/part-II/paragraph-3",
  "json_url": "https://openlegislation.uk/medicines-fees-relating-to-medicinal-products-for-animal-use-regulations-1992/schedule-1/part-II/paragraph-3.json",
  "legislation": "uksi/1992/694",
  "legislation_title": "The Medicines (Fees Relating to Medicinal Products for Animal Use) Regulations 1992",
  "legislation_url": "https://openlegislation.uk/medicines-fees-relating-to-medicinal-products-for-animal-use-regulations-1992",
  "path": "schedule/1/part/II/paragraph/3",
  "kind": "paragraph",
  "number": "3",
  "heading": "Product licences",
  "text": "(1) Subject to sub-paragraphs (2) and (3) below, where an application for a product licence consists of an application for more than one such licence each relating to a product containing the same active ingredient or combination of ingredients, the fee payable under regulation 3(a) shall be an amount equal to the aggregate of the amounts payable under paragraph 1 in respect of separate applications for each such licence.\n(2) If the application is a major application, the amount payable shall be the amount payable in respect of a major application under paragraph 1 plus—\n(a) in respect of each additional product licence applied for which relates to a medicinal product of a different dosage form, the amount payable in respect of a complex application under paragraph 1; and\n(b) in respect of each additional product licence applied for which relates to a medicinal product of the same dosage form but of a different strength of active ingredient or different combination of active ingredients, the amount payable in respect of a standard application under paragraph 1.\n(3) If the application is a complex application, the amount payable shall be the amount payable in respect of a complex application under paragraph 1 plus—\n(a) in respect of each additional product licence applied for which relates to a medicinal product of a different dosage form, the amount payable in respect of a complex application under paragraph 1; and\n(b) in respect of each additional product licence applied for which relates to a medicinal product of the same dosage form but of a different strength of active ingredient or different combination of active ingredients, the amount payable in respect of a standard application under paragraph 1.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/1992/694/schedule/1/part/II/paragraph/3",
    "retrieved_at": "2026-10-29T14:25:20.711529+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}